Pfenex Inc. (PFNX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10790 ROSELLE STREET SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2020 MRQ | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 55,624 | 56,220 | 57,664 | 81,501 | 106,162 | 45,722 | |||
| Cash and cash equivalent | 55,624 | 56,220 | 57,664 | 81,501 | 106,162 | 45,722 | |||
| Restricted cash and investments | 200 | 200 | 200 | 3,959 | |||||
| Receivables | 5,600 | 207 | 1,938 | 717 | 508 | 1,584 | |||
| Inventory, net of allowances, customer advances and progress billings | 24 | 23 | |||||||
| Inventory | 24 | 23 | |||||||
| Other current assets | 2,308 | 1,851 | 1,705 | 1,878 | 1,694 | 1,753 | |||
| Other undisclosed current assets | 28 | 5,171 | 6 | 2,822 | 2,683 | 3,683 | |||
| Total current assets: | 63,760 | 63,649 | 61,513 | 86,918 | 115,030 | 52,765 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 779 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, right-of-use asset | 3,124 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 7,744 | 7,671 | 7,397 | 5,246 | 3,179 | 2,310 | |||
| Intangible assets, net (including goodwill) | 9,310 | 9,825 | 10,348 | 10,878 | 11,409 | 11,940 | |||
| Goodwill | 5,577 | 5,577 | 5,577 | 5,577 | 5,577 | 5,577 | |||
| Intangible assets, net (excluding goodwill) | 3,733 | 4,248 | 4,771 | 5,301 | 5,832 | 6,363 | |||
| Restricted cash and investments | 3,955 | ||||||||
| Other noncurrent assets | 170 | 133 | 133 | 80 | 121 | 53 | |||
| Other undisclosed noncurrent assets | 1,955 | ||||||||
| Total noncurrent assets: | 21,127 | 17,629 | 17,878 | 16,204 | 16,664 | 18,258 | |||
| TOTAL ASSETS: | 84,887 | 81,278 | 79,391 | 103,122 | 131,694 | 71,023 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 8,024 | 11,817 | 10,818 | 10,696 | 8,559 | 5,179 | |||
| Taxes payable | 1,676 | ||||||||
| Employee-related liabilities | 1,417 | ||||||||
| Accounts payable | 673 | 2,005 | 1,905 | 1,284 | 886 | 1,129 | |||
| Accrued liabilities | 7,351 | 9,812 | 8,913 | 9,412 | 5,997 | 2,633 | |||
| Deferred revenue | 75 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 951 | 316 | 228 | 3,813 | 3,813 | ||||
| Other liabilities | 616 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 7,421 | 6,516 | 3,870 | 201 | ||
| Other undisclosed current liabilities | 5,317 | (1,417) | |||||||
| Total current liabilities: | 9,666 | 17,450 | 18,467 | 17,212 | 16,242 | 7,776 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 419 | ||||||||
| Capital lease obligations | ✕ | ✕ | 419 | ||||||
| Liabilities, other than long-term debt | 26 | 191 | 2,742 | 5,765 | 44,271 | 3,373 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 2,742 | 5,739 | 44,225 | |||
| Deferred tax liabilities, net | ✕ | ✕ | 3,281 | ||||||
| Other liabilities | 26 | 191 | 26 | 46 | 92 | ||||
| Other undisclosed noncurrent liabilities | 2,896 | 2,500 | |||||||
| Total noncurrent liabilities: | 2,922 | 2,691 | 3,161 | 5,765 | 44,271 | 3,373 | |||
| Total liabilities: | 12,588 | 20,141 | 21,628 | 22,977 | 60,513 | 11,149 | |||
| Equity | |||||||||
| Equity, attributable to parent | 72,299 | 61,137 | 57,763 | 80,145 | 71,181 | 59,874 | |||
| Common stock | 33 | 32 | 24 | 24 | 24 | 21 | |||
| Additional paid in capital | 270,008 | 262,405 | 219,446 | 216,144 | 212,661 | 173,141 | |||
| Accumulated deficit | (197,742) | (201,300) | (161,707) | (136,023) | (141,504) | (113,288) | |||
| Total equity: | 72,299 | 61,137 | 57,763 | 80,145 | 71,181 | 59,874 | |||
| TOTAL LIABILITIES AND EQUITY: | 84,887 | 81,278 | 79,391 | 103,122 | 131,694 | 71,023 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 50,326 | 14,857 | 28,780 | 60,194 | 9,583 | 10,644 | ||
| Cost of revenue | (4,891) | (5,022) | (5,156) | (5,313) | (4,640) | (7,233) | ||
| Gross profit: | 45,435 | 9,835 | 23,624 | 54,881 | 4,943 | 3,411 | ||
| Operating expenses | (44,611) | (49,686) | (49,599) | (49,758) | (32,781) | (13,128) | ||
| Operating income (loss): | 824 | (39,851) | (25,975) | 5,123 | (27,838) | (9,717) | ||
| Nonoperating income | 235 | 258 | 119 | 149 | 74 | |||
| Interest and debt expense | (77) | |||||||
| Income (loss) from continuing operations before income taxes: | 1,059 | (39,593) | (25,856) | 5,272 | (27,764) | (9,794) | ||
| Income tax expense (benefit) | (1) | 172 | 209 | (452) | ||||
| Income (loss) from continuing operations: | 1,058 | (39,593) | (25,684) | 5,481 | (28,216) | (9,794) | ||
| Income (loss) before gain (loss) on sale of properties: | 1,058 | (39,593) | (25,684) | 5,481 | (28,216) | (9,794) | ||
| Net income (loss) available to common stockholders, diluted: | 1,058 | (39,593) | (25,684) | 5,481 | (28,216) | (9,794) | ||
Comprehensive Income ($ in thousands)
| 6/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,058 | (39,593) | (25,684) | 5,481 | (28,216) | (9,794) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,058 | (39,593) | (25,684) | 5,481 | (28,216) | (9,794) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.